2012ESH+经皮腔内去肾交感神经术治疗顽固性高血压专家立场声明.pdfVIP

ESH Statement ESH Position Paper: Renal denervation ^ an interventional therapy of resistant hypertension a b c,k d e Roland E. Schmieder , Josep Redon , Guido Grassi , Sverre E. Kjeldsen , Giuseppe Mancia , Krzysztof Narkiewiczf g h i , Gianfranco Parati , Luis Ruilope , Philippe van de Borne , and Costas Tsioufisj According to the European Society of Hypertension Experts from the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) and Seventh prepared this position paper in order to summarize current report of the Joint National Committee on Prevention, evidence, unmet needs and practical recommendations on Detection, Evaluation and Treatment of High Blood Pres- the application of percutaneous transluminal ablation of sure (JNC 7) guidelines, resistant hypertension is defined as renal nerves [renal denervation (RDN)] as a novel persistence of BP levels above goal in spite of the con- therapeutic strategy for the treatment of resistant current use of three antihypertensive agents in adequate hypertension. The sympathetic nervous activation to the doses from different classes including a diuretic [5,6]. The kidney and the sensory afferent signals to the central exact prevalence of resistant hypertension is